-
Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal
biospace
December 28, 2017
Mallinckrodt, based in Staines-Upon-Thames, UK, is acquiring Rockville, Maryland-based Sucampo Pharmaceuticals for $1.2 billion.
-
Roche boosts oncology portfolio with $1.7bn acquisition
pharmafile
December 25, 2017
Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for $1.7 billion.
-
Centinel Spine Completes Acquisition of prodisc Assets
prnasia
December 25, 2017
Centinel Spine, LLC (CS) is pleased to announce the acquisition of the worldwide assets of the prodisc® Total Disc Replacement portfolio from DePuy Synthes Products, Inc.
-
JSR Life Sciences Snaps Up CRO in $400M Deal
biospace
December 21, 2017
The parent company of JSR Life Sciences snapped up contract research organization Crown Bioscience International for $400 million, the company announced this morning.
-
Malaysia based Chemopharm acquired by Everstone Group
biospectrumasia
November 27, 2017
Singapore-based Cure Capital acted as a co-investor in the transaction.
-
Shanghai Pharma buys drug distribution unit of US-based Cardinal Health
biospectrumasia
November 22, 2017
Shanghai Pharma and Cardinal Health have reached a strategic cooperation agreement to explore business development in the U.S., as well as collaborate in developing the global market for medical equipment and service innovation.
-
Tucson Startup Revolutionary Medical Devices bought by Chicago firm
biospectrumasia
November 07, 2017
Vyaire, formerly known as CareFusion, has been assembling a line of respiratory products through acquisitions.
-
Factory CRO announces acquisition of Milestone Research Organization
pharmaasia
November 06, 2017
Global contract research organisation Factory CRO expands its operations to North America with the acquisition of San Diego-based Milestone Research.
-
China’s Fosun Pharma takeover of an Indian pharma giant
biospectrumasia
October 27, 2017
The deal will help the Chinese company make inroads into India, gain access to US injectable drug market where Gland has a firm hold and bolster its product portfolio
-
China Biologic plans acquisition of TianXinFu
biospectrumasia
October 16, 2017
China Biologic will issue 5,521,000 ordinary shares to PW Medtech.